// App-Quantinova.ai

S206 : OBINUTUZUMAB PLUS CHEMOTHERAPY DEMONSTRATES LONG-TERM BENEFIT OVER RITUXIMAB PLUS CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: FINAL ANALYSIS OF THE GALLIUM STUDY

Researchers

Presenter

  • William Townsend

Principal Investigators

  • Wolfgang Hiddemann

  • Christian Buske

  • Guillaume Cartron

  • David Cunningham

  • Martin J.S. Dyer

  • John Gribben

  • Elizabeth Phillips

  • Martin Dreyling

  • John F. Seymour

  • Andrew Grigg

  • Tong-Yu Lin

  • Xiao-Nan Hong

  • Dirk Kingbiel

  • Tina G. Nielsen

  • Andrea Knapp

  • Michael Herold

  • Robert Marcus

Medical Centers

  • HELIOS-Klinikum Erfurt, Erfurt ,Deutschland

  • Roche - F.Hoffman-La Roche Ltd,Basel,Швейцария

  • CHU de Montpellier, Montpellier, France

  • CHU de Montpellier, Montpellier, France

  • Haematologiy,Royal Free Hospital,London,Royaume-uni

  • Kings College Hospital,

  • Ernest and Helen Scott Haematological Research Institute, University of Leicester,Leicester,Royaume-uni

  • Barts Cancer Institute, Queen Mary University of London,London,Royaume-uni

  • HELIOS Klinikum Erfurt GmbH, Erfurt, Germany

  • HELIOS-Klinikum Erfurt, Erfurt ,Deutschland

  • Universtitätsklinikum Ulm,Ulm,Alemanha

  • King's College Hospital,London,Reino Unido

  • Ludwig-Maximilians-University Hospital Munich,Munich,Alemania

  • Cancer Research UK and UCL Cancer Trials Centre, University College Hospitals London,London,Vereinigtes Königreich

  • Haematologiy,Royal Free Hospital,London,Royaume-uni

  • Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Austin Hospital,Austin,Austrália

  • Fudan University Shanghai Cancer Center, Shanghai, China

  • CHU de Montpellier, Montpellier, France

  • Universitatsklinikum Ulm, Ulm, Germany

  • Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia

  • HELIOS-Klinikum Erfurt, Erfurt ,Deutschland

  • Ludwig-Maximilians-Unive

  • HELIOS-Klinikum Erfurt, Erfurt ,Германия

  • Ludwig-Maximilians-Universität München,Munich,Deutschland

  • F. Hoffmann-La Roche Ltd ,Basel,Suisse

  • Fudan University Shanghai Cancer Center, Shanghai, China

  • Ludwig Maximilians University Munich, Munich, Germany

  • Ernest and Helen Scott Haematological Research Institute, University of Leicester,Leicester,Royaume-uni

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Austin Hospital,Austin,Austrália

  • Austin Hospital,Austin,Австралия

  • Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, guangzhou, China.

  • F. Hoffmann-La Roche Ltd ,Basel,Suisse

  • Cancer Research UK and UCL Cancer Trials Centre, University College Hospitals London,London,Vereinigtes Königreich

  • The Ernest and Helen Scott Haematological Research Institute, University of Leicester

  • Fudan University Shanghai Cancer Center, Shanghai, China

  • Cancer Research UK and UCL Cancer Trials Centre, University College Hospitals

  • Royal Marsden Hospital,London,Vereinigtes Königreich

  • Universtitätsklinikum Ulm,Ulm,Duitsland

  • Ludwig-Maximilians-University Hospital Munich,Munich,Alemania

  • Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Universtitätsklinikum Ulm,Ulm,Alemanha

  • Universtitätsklinikum Ulm,Ulm,Alemanha

  • Royal Marsden Hospital,London,Vereinigtes Königreich

  • HELIOS-Klinikum Erfurt, Erfurt ,Deutschland

  • Ernest and Helen Scott Haematological Research Institute, University of Leicester,Leicester,Royaume-uni

  • F. Hoffmann-La Roche Ltd ,Basel,Suisse

  • CHU de Montpellier, Montpellier, France

  • Royal Marsden Hospital,London,Соединённое Королевство

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • CHU Montpellier,Montpellier,Frankreich

  • Austin Hospital,Austin,Austrália

  • Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

  • Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

  • Kings College London, London, United Kingdom

  • King's College Hospital,London,Reino Unido

  • Kings College Hospital,London,Verenigd Koninkrijk

  • Royal Marsden Hospital, Sutton, UK

  • Universtitätsklinikum Ulm,Ulm,Duitsland

  • Austin Hospital,Austin,Austrália

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Universitatsklinikum Ulm, Ulm, Germany

  • CHU de Montpellier,Montpellier,Франция

  • Royal Marsden Hospital,Sutton,Regno Unito

  • Austin Hospital,Austin,Austrália

  • Ludwig-Maximilians-University Hospital Munich,Munich,Alemania

  • University of Manchester, The Christie Hospital and National Institutes of Health Res

  • F. Hoffmann-La Roche Ltd ,Basel,Suisse

  • Ludwig-Maximilians-University Hospital Munich,Munich,Alemania

  • Cancer Research UK and UCL Cancer Trials Centre, University College London, London, United Kingdom

  • Haematology,King's College Hospital,London,Соединённое Королевство

  • Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Universtitätsklinikum Ulm,Ulm,Duitsland

  • Royal Marsden Hospital, Surrey, United Kingdom

  • CHU Montpellier,Montpellier,Frankreich

  • University of Manchester, The Christie Hospital and National Institutes of Health Research Manchester Biomedical Research Centre,Manchester,Vereinigtes Königreich

  • Furman University

  • HELIOS-Klinikum Erfurt, Erfurt ,Deutschland

  • Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia

  • HELIOS-Klinikum Erfurt, Erfurt ,Deutschland

  • Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia

  • Universitätsklinikum Ulm,Ulm,Германия

  • University of Manchester, The Christie Hospital and National Institutes of Health Research Manchester Biomedical Research Centre,Manchester,Vereinigtes Königreich

  • King's College Hospital,London,Royaume-uni

  • Kings College Hospital,London,Vereinigtes Königreich

  • HELIOS-Klinikum Erfurt, Erfurt ,Deutschland

  • Barts Cance

Locations

  • United Kingdom

  • Germany

  • France

  • United States

  • Australia

  • China

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Follicular lymphoma

Biomarkers

  • DNA Damage Inducible Transcript 3

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Obinutuzumab

  • Obinutuzumab Intravenous

  • Bendamustine

  • Prednisolone

  • Vincristine

  • Doxorubicin

  • Rituximab

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • NCT01332968

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved